The Polio Eradication and Endgame Strategic Plan

Slides:

Advertisements

Similar presentations

Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.

Advertisements

Update on Vaccines not Included in this Tender: Rotavirus Vaccines Pre Tender Meeting UNICEF Supply Division, 10-11th December 2008 Ann Ottosen.

Module 1 Introduction to the polio endgame rationale and IPV vaccine

1 |1 | Countries using and planning to introduce IPV.

Expert Review Committee Meeting March  Recent Nigeria cold chain assessments and EPI committee recommendations ◦ Review wastage rates and further.

1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.

World Health Organization

1 |1 | Countries using and planning to introduce IPV.

UN Prequalification: UNICEF Perspective 5 th UN Prequalification stakeholders meeting 11th February 2009.

WHO RAP Team: Perspective and Update WORKSHOP ON ANALYZING THE POLIO ERADICATION ENDGAME, Seattle, 1-2 July 2015.

Global Polio Eradication Initiative Surveillance, Operation and Monitoring Vaccine Procurement, Communication and Social Mobilization Advocacy, Funding.

Completing The Endgame Global Polio Eradication

Measles Partnership Meeting Yalda Momeni September 23 rd - WDC.

The Evolving 'Polio Endgame' Strategy

Conclusions & Recommendations 24 th IEAG March 2012.

Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.

Polio End-game: What are the implications on polio vaccination policy? Dr Raju Shah.

The Challenge: How to Accelerate Eradication and the 'Endgame'?

1 |1 | Countries using and planning to introduce IPV.

Expanded Program of Immunization Dr. Faten M. Rabie.

Introduction of Hib in UIP Dr. Prashant P. Ghodam Moderator : Dr. Ranjan Solanki.

DRAFT V1 National Vaccine Supply Chain Innovations: Country Commitment to Ownership, Sustainability & Impact GAVI Partners’ Forum WHO – UNICEF – GAVI -

Vaccine Landscape Implications for 202X May 2, 2011.

1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global.

Polio Eradication and End Game Strategy

JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.

Measles Partnership Meeting Update on Vaccine Supply Washington, 27-28th February 2007 UNICEF Supply Division.

Withdrawal of OPV type 2 in India

Polio Endgame Strategy in India Considerations and Way Forward WHO-India, NPSP 15 March 2012.

Status of EPI In Guinea DR. Mariama BAH Child Survival Advisor USAID/Guinea June 13, 2002.

WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.

Polio Research Activities in India Dr Sunil Bahl WHO-India, NPSP 15 March 2012.

Rebecca Bell Balsillie School of International Affairs school.ca THE ROAD TO GLOBAL POLIO ERADICATION: CHALLENGES AND OPPORTUNITIES.

National Immunization Program (NIP)/Advisory Committee on Immunization Practices (ACIP) Report Stephen L. Cochi, MD, MPH Acting Director, National Immunization.

Module 4 IPV vaccine administration Training for Inactivated Poliovirus Vaccine (IPV) introduction.

February 2015 An introduction to the switch from trivalent to bivalent oral polio vaccines 1.

Module 7 Communicating with parents, caregivers and health personnel about IPV and multiple injections Training for Inactivated Poliovirus Vaccine (IPV)

Module 3 IPV schedule, eligibility and contraindications Training for Inactivated Poliovirus Vaccine (IPV) introduction.

The polio endgame and silent circulation: some related research.

Module 1 Introduction to the polio endgame rationale and IPV vaccine

IPV ACCEPTABILITY PANCONF 2015 Background/ Why the study? Dr Beckie Tagbo Chief Consultant: Paediatrics and Child Health Institute of Child Health (ICH),

Measles Rubella Meeting

Poliomyelitis Dr. Asif Rehman.

ROTAVIRUS COMMON, SEVERE, DEVASTATING, PREVENTABLE

Perspective and Update

Introduction to the polio endgame rationale and IPV vaccine

The next phase of polio eradication and the vaccines used

Immunization Systems Management Group (IMG)

Immunization Systems Management Group (IMG)

The next phase of polio eradication and the vaccines used

POLIOPLUS FACT SHEET Feb 2018

Progress and Challenges with achieving Universal Immunization Coverage

Module 8 Safety and acceptability of multiple injections

Safety and acceptability of multiple injections

Communicating with caregivers about IPV and multiple injections

Communicating with caregivers about IPV and multiple injections

المرحلة القادمة من القضاء على شلل الأطفال واللقاحات المستخدمة

Global Update on Varicella: Protecting Against an Old Enemy

Independent Monitoring of the Switch

The next phase of polio eradication and the vaccines used

The next phase of polio eradication and the vaccines used

Module 8 Safety and acceptability of multiple injections

Preparing for the Switch

State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.

Kenya Pediatric Association Conference,

Polio Eradication Progress & Challenges.

MenB Update: Communicating the Imperative With Parents

Nili Karako Eyal, School of Law, College of Management, Israel

The next phase of polio eradication and the vaccines used

Presentation transcript:

The Polio Eradication and Endgame Strategic Plan

Part 1: Technical Rationale for IPV Introduction and OPV Withdrawal

GPEI Accomplishment Significant Decline in Paralysis Due to WPVs, 1988 to 2013*

Poliovirus Types

IPV

Number of Cases of cVDPV-related Polio Exceeds the Number of Cases of WPV

Polio Eradication and Endgame Strategic Plan 2013 to 2018

Polio Eradication and Endgame Strategic Plan Objectives

Objective 2 Strengthen Immunization Systems, Introduce IPV, and Withdraw OPV

SAGE Recommendations for the Planned Use of IPV

Introducing at Least 1 Dose of IPV Before the tOPV → bOPV Switch Rationale: Improve Global Population Immunity

Individual Protection Against IPV-induced Paralytic Disease Reducing the Risks

Individual Protection Against IPV-induced Paralytic Disease Reducing the Risks

Individual Protection Against IPV-induced Paralytic Disease Reducing the Risks

Poliovirus Shedding in IPV vs OPV After Virus Vaccine Challenge

IPV and Polio Eradication

Recommended IPV Schedule Key Points

Programmatic Implications of IPV Introduction

Global Introduction of IPV

Introducing IPV in 124 Countries A Coordinated, Multipartner Effort

IPV Vaccine Demand Forecast and Supply

IPV Presentations and Formulations

IPV Prices for Supply Through UNICEF (2014 to 2018)

GAVI Support for IPV GAVI Alliance Board of Director Decisions, November 2013*

Administration of IPV

Advantages of Administering Multiple Injections at Same Visit

IPV Is Temperature Sensitive

IPV Impact of 1-dose Vial on Central-level Cold Chain in DR Congo Is Limited

IPV Multidose Vials

Technical and Communication Resources for Planning and IPV Introduction

Considerations for Planning and Logistics Summary

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)